Susquehanna Fundamental Investments, LLC Gossamer Bio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $123,586 - $255,058	-17,141 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.44 - $12.49 $395,565 - $585,381	-46,868 Reduced 73.22%	17,141 $149,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $43,485 - $60,458	-4,297 Reduced 6.29%	64,009 $724,000
Q3 2021 Nov 15, 2021	BUY	$7.25 - $13.23 $495,218 - $903,688	68,306 New	68,306 $859,000
Q4 2020 Feb 16, 2021	SELL	$8.3 - $13.59 $494,680 - $809,964	-59,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$11.3 - $14.75 $207,920 - $271,400	18,400 Added 44.66%	59,600 $740,000
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $392,224 - $658,376	41,200 New	41,200 $536,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $90.2M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.